Article
Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations.
Clinical genetics - 1 Mar 2013
Narod S A, Moody J R K, Rosen B, Fan I, Risch A, Sun P, McLaughlin J R
Abstract excerpt
Several studies have reported that women with ovarian cancer and a BRCA1 or BRCA2 mutations have better survival than women with ovarian cancer and no mutation. Potential reasons for this include possible differences in histologic subtype, stage, grade and response to chemotherapy, but some of the difference in survival may be due to systematic bias, i.e. a difference in survival rates for women who do and who do...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.